Abstract
BackgroundNatural killer (NK) cells exhibit potent activity in pre-clinical models of diverse hematologic malignancies and solid tumors and infusion of high numbers of NK cells, either autologous or allogeneic, after...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have